ocrelizumab multiple sclerosis clinical trial

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
ocrelizumab multiple sclerosis clinical trial	1.13	0.2	7077	37	45
ocrelizumab	0.89	0.8	7318	33	11
multiple	0.53	0.7	3025	26	8
sclerosis	1.31	0.5	4320	21	9
clinical	0.14	0.2	2570	85	8
trial	1.28	0.4	8965	51	5

Keyword	CPC	PCC	Volume	Score
ocrelizumab multiple sclerosis clinical trial	1.23	0.9	6975	55
ocrelizumab used for multiple sclerosis	0.39	0.7	771	97
ocrelizumab fda approval multiple sclerosis	0.43	0.4	9070	69
multiple sclerosis clinical trial	1.21	0.4	9510	83
ocrelizumab primary progressive ms	1.16	0.2	6190	67
clinical trials multiple sclerosis	1.56	0.3	8140	64
ocrelizumab multiple sclerosis side effects	1.01	0.6	7661	36
ms infusion ocrelizumab vs ocrevus	0.39	0.8	8877	68
ms infusion ocrelizumab reviews	1.08	0.4	8321	43
multiple sclerosis drugs in clinical trials	1.88	0.7	3523	77
clinical trials near me multiple sclerosis	1.4	1	6536	73
new multiple sclerosis trials	0.68	0.3	1479	28
multiple sclerosis drug trial	1.09	0.8	6709	17
ann 2023 ofatumumab multiple sclerosis	1.45	0.9	1577	5
ms infusion ocrelizumab infusion protocol	0.92	0.8	575	67
clinical trial for ms	0.15	0.7	1689	70
ms clinical trials 2023	1.32	0.1	8756	62
injection ocrelizumab 1 mg	0.16	0.3	4237	54
is ocrelizumab a chemo drug	0.26	1	2172	10
ocrelizumab mechanism of action	1.71	0.6	9366	95
is ocrelizumab an immunosuppressant	0.85	0.3	3064	77